← Back to all trials
Recruiting
NCT05652946
IISART (International Industry Society of Advanced Rehabilitation Technology) Advanced Rehabilitation Technology Study
Conditions: Neurologic Disorder
Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 200
Sponsor: Rehabilitation Hospital of Overland Park
Location: United States
Summary
A pre-post, randomized control trial comparing cost-effective and functional outcomes of participants with neurological diagnoses using robotic devices and advanced technology during inpatient rehabilitation to the outcomes of control participants without the use of robotic devices and advanced technology during rehabilitation.
We aim to show at least similar inpatient rehabilitation outcomes and improved health economics in participants with neurological diagnoses by using robotic devices and advanced technology to increase the intensity and dose of rehabilitation.
Eligibility Criteria
Inclusion Criteria:Currently admitted for inpatient rehabilitation at Rehabilitation Hospital Overland Park with neurological diagnosis.At least 18 years of age.Predicted length of stay to be at least 7 days.Able to tolerate upright sitting without orthostatic hypotension for upper extremity, cycling, and sitting balance devices AND/OR able to tolerate upright standing for at least 15 minutes without orthostatic hypotension for walking and standing balance devices.Able to fit into at least one device.Screened and cleared by a physician.Cognitively intact to communicate pain and/or need to stop session, and able to follow simple commands.Exclusion Criteria:Current or history of other medical conditions that could affect the outcome measures.Currently involved in another intervention study.Any absolute contraindication listed for each device used.Any pre-existing physical or medical condition that the Physiatrist determines would significantly limit a patient's ability to benefit from or continue in the study.
Source: ClinicalTrials.gov (NCT05652946). StuddyBuddy aggregates publicly available trial information.